Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: In vitro study

Arzneimittel-Forschung/Drug Research

Volumn 60, Issue 11, 2010, Pages 675-681

  Braga, Pier Carlo ^a   Dal Sasso, Monica ^a   Culici, Maria ^a   Spallino, Alessandra ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antimicrobials; CAS 89 83 8; Fluorescence microscopy; Gardnerella vaginalis; Mature biofilm; Native biofilm

Indexed keywords

ESSENTIAL OIL; PROPIDIUM IODIDE; THYMOL;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOFILM; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; FLUORESCENCE MICROSCOPY; GARDNERELLA INFECTION; GARDNERELLA VAGINALIS; IN VITRO STUDY; MICROTITER PLATE ASSAY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPECTROPHOTOMETRY;

EID: 78649842346     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296346     Document Type: Article

References (48)

1. Reid G, Heinemann C, Howard J, Gardner G, Gan BS. Understanding urogenital biofilms and potential impact of probiotics. Methods Enzymol. 2001;336:403-10.
2. Schwebke JR, Richey CM, Weiss HL. Correlation of behaviour with microbiological changes in vaginal flora. Infect Dis. 1999;180:1632-6.
3. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Clamydia trachomatis infection. Clin Infect Dis. 2003;36:663-8.
4. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis. 2003;37:319-25.
5. Miller L. Can Fem Exam card use facilitate bacterial vaginosis diagnosis on day of abortion to prevent postabortion endometritis? AmJ Obstet Gynecol. 2001;197:58-9.
6. Peipert JF, Montagno AB, Cooper AS, Sung CJ. Bacterial vaginosis as a risk factor upper genital tract infection. Am J Obstet Gynecol. 1997;177:1184-7.
7. Sobel JD. What's new in bacterial vaginosis and trichomoniasis? Infect Dis Clin North Am. 2005;19:387-406.
8. Sobel JD. Bacterial vaginosis. Annu Rev Med. 2000;51:349-56.
9. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353:1899-1911.
10. Verstraelen H, Verhelst R, Claeyes G, Temmerman M, Vaneechoutte M. Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis. AmJ Obstet Gynecol. 2004;191:1130-32.
11. Patterson JL, Girerd PH, Karjane NW, Jefferson KK. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol. 2007;197:170e1-170e7.
12. Costerton JW, Steward PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318-22.
13. Costerton JW, Veeh M, Shirtliff M, Pasmore M, Post C, Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections. Clin Invest. 2003;112:1466-77.
14. Srinivasan S, Fredricks DN. The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis. 2008:750479. Epub 2009 Feb 16.
15. Swidsinski A, Mendling W, Loening-Baucke V, Ladhoff A, Swidsinski S, Hale LP, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005;106:1013-23.
16. Swidsinski A, Mendling W, Loening-Baucke V, Swindinski S, Dorffel Y, Scholze J, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. AmJ Obstet Gynecol. 2008;198:97e1-97e7.
17. Schwiertz A, Duttke C, Hild J, Muller HJ. In vitro activity of essential oils on microorganisms isolated from vaginal infections. Int J Aromather. 2006;16:169-74.
18. Leung AY, Foster S. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. 2nd ed. New York: John Wiley & Sons; 1996. pp. 492-5.
19. van den Broucke CO. The therapeutic value of Thymus species. Fitoterapia. 1993;4:171-4.
20. Rasooli I, Mirmostafa SA. Antibacterial properties of Thymus pubescens and Thymus serpyllum essential oils. Fitoterapia. 2002;13:244-50.
21. Cosentino S, Tuberoso CIG, Pisano B, Satta M, Mascia V, Arredi E, et al. In vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils. Lett Appl Microbiol. 1999;29:130-5.
22. Marino M, Bersani C, Comi G. Antimicrobial activity of the essential oils of Thymus vulgaris L measured using bioimpedometric method. J Food Protect. 1999;62:1017-23.
23. Tacconi E, Portalupi P, Camana MG, et al. Le proprietà antimicrobiche dell'estratto di timo: confronto dell'attività esercitata su patogeni e su un simbionte umano (Lactobacillus acidophilus). Riv Ostet Ginecol Pratica Med Perinatale. 2003;18:1-4. Italian.
24. Portalupi P, Camana MG, Tacconi E, et al. Comparative experimental study on antibacterial and antimicotic activity of Thymus vulgaris and econazole. Giorn It Microbiol Medica Odont Clin. 2003;7:1-8.
25. Lambert RJW, Skandamis PN, Coote PJ, Nychas GJE. A study on the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J Appl Microbiol. 2001;91:453-62.
26. Didry N, Dubreuil L, Pinkas M. Activity of thymol, carvacrol, cinnamaldehyde and eugenol on oral bacteria. Pharmacol Acta Helv. 1994;69:25-8.
27. Karapinar M, Aktug SE. Inhibition of foodborne pathogens by thymol, eugenol, menthol and anethole. Int J Food Microbiol. 1987;4:161-6.
28. Braga PC, Spallino A, Sturla C, Culici M, Dal Sasso M. Effects of thymol on the adhesiveness of Gardnerella vaginalis to human vaginal cells. Giorn It Microbiol Medica Odont Clin. 2010;14:1-8.
29. Dal Sasso M, Culici M, Guffanti EE, Mucci M, Braga PC. Thymol: inhibitory activity on Escherichia coli and Staphylococcus aureus adhesion to human vaginal cells. J Essent Oil Res. 2006;18:455-61.
30. Rasooli I, Mirmostafa SA. Bacterial susceptibility to and chemical composition of essential oils from Thymus Kotschyamus and Thymus persicus. J Agric Food Chem. 2003;51:2200-5.
31. Perez-Giraldo C, Rodriguez-Benito A, Moran FJ, Hurtado C, Blanco MT, Gomez-Garcia AC. In vitro slime production by Staphylococcus epidermidis in presence of subinhibitory concentrations of ciprofloxacin, ofloxacin and sparfloxacin. J Antimicrob Chemother. 1994;33:845-8.
32. Muli F, Struthers JK. Use of continuous-culture biofilm system to study the antimicrobial susceptibility of Gardnerella vaginalis and Lactobacillus acidophilus. Antimicrob Agents. Chemother 1998;42:1428-32.
33. Schwebke JR. Gynecologic consequence of bacterial vaginosis. Obstet Gynecol Clin North Am. 2003;30:685-94.
34. Larsson PG, Forsum U. Bacterial vaginosis - a disturbed bacterial flora and treatment enigma. Acta Pathol Microbiol Immunol. 2005;113:305-16.
35. LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal- tolerant persister cells. Antimicrob Agents Chemother. 2006;50:3839-46.
36. Ergin A, Arikan S. Comparison of microdilution and disc diffusion methods in assessing in vitro activity of fluconazole and Melaleuca alternifolia (tea tree) oil against vaginal Candida isolates. J Chemother. 2002;14:465-72.
37. Hammer KA, Carson CF, Riley TV. In vitro susceptibility of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrob Agents Chemother. 1999;43:196.
38. Braga PC, Culici M, Alfieri M, Dal Sasso M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. J Antimicrob Agents. 2008;31:472-7.
39. Pina-Vaz C, Goncalves Rodriguez A, Pinto E, Costa-de-Oliveira S, Tavares C, Salgueiro L, et al. Antifungal activity of thymus oils and their major compounds. J Eur Acad Derm Vener. 2004;18:73-8.
40. Nostro A, Sudano Roccaro A, Bisignano G, Marino A, Cannatelli MA, Pizzimenti FC, et al. Effects of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Med Microbiol. 2007;56:519-23.
41. Helander IM, Alakomi HL, Latva-Kala K, Mattila-Sandholm T, Pol I, Smid EJ, et al. Characterization of the action of selected essential oil components on Gram-negative bacteria. J Agric Food Chem. 1998;46:3590-5.
42. Lambert RJW, Skandamis PN, Coote PJ, Nychas GJE. A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J Appl Microbiol 2001;91:453-62.
43. Trombetta D, Castelli F, Sanpietro MG, Venuti V, Cristani M, Daniele C, et al. Mechanisms of antibacterial action of three monoterpenes. Antimicrob Agents Chemother. 2005;49:2474-8.
44. Ultee A, Kets EPW, Smid J. Mechanisms of action of carvacrol on the food-borne pathogen Bacillus cereus. Appl Environ Microbiol. 1999;65:4606-10.
45. Oussalah M, Caillet S, Lacroix M. Mechanism of action of Spanish oregano, Chinese cinnamon, and savory essential oils against cell membranes and walls of Escherichia coli O157:H7 and Listeria monocytogenes. J Food Protect. 2006;69:1046-55.
46. Griffin SG, Wyllie SG, Markham JL, Leach D. The role of structure and molecolar properties of terpenoids in determining their antimicrobial activity. Flavour Fragr. 1999;14:322-32.
47. Ouhayoun JP. Penetrating the plaque biofilm: impact of essential oil mouthwash. J Clin Periodontol. 2003;30 (Suppl. 5):10-12.
48. Knowles JR, Roller S, Murray DB, Naidu AS. Antimicrobial action of carvacrol at different stages of dual-species biofilm development by Staphylococcus aureus and Salmonella enterica serovar Thyphimurium. Appl Environ Microbiol. 2005;71:797-803.